![\"\"](\"\/care\/files\/2026\/09\/IMG_4689-rotated.jpeg\")
<\/a>Daniel Alford, MD, MPH<\/a><\/strong><\/span><\/p>\n Managing opioid use disorders and safer and more competent opioid prescribing for managing pain<\/span><\/p>\n Sarah Bagley, MD, MSc<\/strong><\/a><\/span><\/p>\n Engagement of young adults who use drugs and their families in care to minimize risk for overdose and the complications of drug use<\/span><\/p>\n Cecily Barber, MD, MPH<\/a><\/span><\/strong><\/p>\n Obstetrics and Gynecology, Maternal Health and Addiction Medicine<\/span><\/p>\n Deborah Chassler, MSW<\/a><\/span><\/strong><\/p>\n Substance use disorders with an emphasis on evaluation research with community partners providing addiction treatment services<\/span><\/p>\n Avik Chatterjee, MD, MPH<\/strong><\/a><\/span><\/p>\n Innovative treatment models for opioid use disorder in marginalized populations and interventions on social determinants of health, such as food insecurity. Also, racism and health care, particularly its manifestations in medical education and training<\/span><\/p>\n Danielle Haley, MPH, PhD<\/strong><\/a><\/span><\/p>\n Social determinants of health, with a focus on how features of the social and built environment, especially health policies, create disparities in health and health care utilization among people with or at increased risk for HIV<\/span><\/p>\n Miriam Harris, MD, MSc<\/strong><\/a><\/span><\/p>\n The intersection of women\u2019s health and substance use, including increasing sexual, reproductive, and HIV prevention services in substance use treatment spaces; substance use treatment while pregnant and parenting; and gender-responsive harm reduction<\/span><\/p>\n Emily Hurstak, MD, MPH<\/strong><\/a><\/span><\/p>\n Improving the understanding and care of patients with co-morbid substance use disorders and chronic pain as well as studying health literacy and health communication techniques to improve care of vulnerable patients<\/span><\/p>\n Theresa Kim, MD<\/strong><\/a><\/span><\/p>\n The impact of housing instability, depression, and substance use on access to care for people with HIV infection; defining and measuring the quality of medical care on addiction outcomes; screening and brief intervention for unhealthy alcohol and drug use in general medical settings<\/span><\/p>\n Marc Larochelle, MD, MPH<\/strong><\/a><\/span><\/p>\n \u00a0The safety of opioid prescribing and the recognition and treatment of opioid use disorders<\/span><\/p>\n Benjamin Linas, MD<\/strong><\/a><\/span><\/p>\n Hepatitis-C virus (HCV) infection and HCV\/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods<\/span><\/p>\n Karsten Lunze, MD, MPH, DrPH<\/strong><\/a><\/span><\/p>\n Access to quality care for disadvantaged people; s<\/span>tigma, HIV prevention, and care in key populations; b<\/span>ehavioral interventions in humanitarian settings; i<\/span>mplementation Science; g<\/span>lobal maternal and newborn health<\/span><\/p>\n Tibor Palfai, PhD<\/strong><\/a><\/span><\/p>\n Understanding the cognitive-motivational processes underlying health risk behaviors (e.g., hazardous\/harmful drinking, substance use, risky sexual decisions) and developing psychological interventions to reduce these risks<\/p>\n Jeffrey Samet, MD, MPH<\/strong><\/a><\/span><\/p>\n Alcohol and drug use, HIV infection, primary medical care<\/span><\/p>\n Kaku So-Armah, PhD<\/strong><\/a><\/span><\/p>\n Substance use and chronic infections like human immunodeficiency virus (HIV), and tuberculosis (TB) and how these exposures impact the heart, liver and lungs<\/p>\n Carl Streed, MD, MPH<\/strong><\/a><\/span><\/p>\n The health and well-being of marginalized persons, particularly sexual and gender minority populations (e.g., lesbian, gay, bisexual, transgender, and queer [LGBTQ] persons)<\/span><\/p>\n Alyssa Tilhou, MD, PhD<\/strong><\/a><\/span><\/p>\n Access and utilization of primary care and substance use services in low-income populations<\/span><\/p>\n Alexander Walley, MD, MSc<\/strong><\/a><\/span><\/p>\n The medical complications of substance use, specifically HIV and overdose; the opioid crisis and the integration of addiction specialty care and general medical care; community overdose interventions, including post-overdose outreach programs and overdose prevention hotlines<\/span><\/p>\n Zoe Weinstein, MD, MS<\/strong><\/a><\/span><\/p>\n Inpatient addiction care, long-term Office-Based Addiction Treatment (OBAT) with buprenorphine<\/span><\/p>\n